Department of Histology and Embryology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.
J Exp Med. 2010 Nov 22;207(12):2663-73. doi: 10.1084/jem.20100921. Epub 2010 Nov 15.
Cytomegaloviruses (CMVs) are renowned for interfering with the immune system of their hosts. To sidestep antigen presentation and destruction by CD8(+) T cells, these viruses reduce expression of major histocompatibility complex class I (MHC I) molecules. However, this process sensitizes the virus-infected cells to natural killer (NK) cell-mediated killing via the "missing self" axis. Mouse cytomegalovirus (MCMV) uses m152 and m06 encoded proteins to inhibit surface expression of MHC I molecules. In addition, it encodes another protein, m04, which forms complexes with MHC I and escorts them to the cell surface. This mechanism is believed to prevent NK cell activation and killing by restoring the "self" signature and allowing the engagement of inhibitory Ly49 receptors on NK cells. Here we show that MCMV lacking m04 was attenuated in an NK cell- and MHC I-dependent manner. NK cell-mediated control of the infection was dependent on the presence of NK cell subsets expressing different inhibitory Ly49 receptors. In addition to providing evidence for immunoevasion strategies used by CMVs to avoid NK cell control via the missing-self pathway, our study is the first to demonstrate that missing self-dependent NK cell activation is biologically relevant in the protection against viral infection in vivo.
巨细胞病毒(CMV)以干扰宿主的免疫系统而闻名。为了逃避 CD8(+) T 细胞的抗原呈递和破坏,这些病毒会降低主要组织相容性复合体 I 类(MHC I)分子的表达。然而,这一过程通过“自身缺失”轴使病毒感染的细胞对自然杀伤(NK)细胞介导的杀伤敏感。小鼠巨细胞病毒(MCMV)利用 m152 和 m06 编码的蛋白抑制 MHC I 分子的表面表达。此外,它还编码另一种蛋白 m04,该蛋白与 MHC I 形成复合物,并将其运送到细胞表面。这种机制被认为可以通过恢复“自身”特征并允许 NK 细胞上的抑制性 Ly49 受体结合来防止 NK 细胞的激活和杀伤。在这里,我们表明,缺乏 m04 的 MCMV 以依赖 NK 细胞和 MHC I 的方式衰减。NK 细胞介导的感染控制依赖于表达不同抑制性 Ly49 受体的 NK 细胞亚群的存在。除了为 CMV 通过缺失自身途径逃避 NK 细胞控制而使用的免疫逃避策略提供证据外,我们的研究首次表明,缺失自身依赖的 NK 细胞激活在体内保护免受病毒感染方面具有生物学相关性。
Cell Rep. 2020-7-28
Cell Mol Immunol. 2024-9
Proc Natl Acad Sci U S A. 2010-4-26
J Immunol. 2010-3-1
Nat Immunol. 2010-2-28
Proc Natl Acad Sci U S A. 2009-7-7
Curr Protoc Immunol. 2001-8